AIMS Institute conducts IRB-approved prospective clinical outcomes studies to evaluate the safety and effectiveness of our therapy programs. We ask all of our patients to participate.
AIMS Institute is working with the U.S. FDA and DEA towards conducting the first human study of ayahuasca tea therapy in the U.S.
Dr. Standish has been principal investigator on numerous clinical studies funded by the National Institutes of Health.
Dr. Aggarwal, as a National Science Foundation Graduate Research Fellow, was the principal investigator on the first study with state-authorized medical cannabis patients conducted under NIH-issued federal Certificates of Confidentiality. His peer-reviewed publications have been cited over 500 times.
Dr. Aggarwal and Standish are both experienced physicians and scientists.
Read some of their publications below.